Tracking TSHA? Get live short interest, options flow, and signals on ORTEX.Sign up free →
TS
Taysha Gene Therapies, Inc. (TSHA) short interest & options flow
NASDAQTaysha Gene Therapies reports this morning with short sellers sitting on a 16.5% short interest position — one of the larger bets against a clinical-stage biotech in the gene therapy space — while every analyst covering the stock carries a buy-equivalent rating and a price target well above last night's close of $6.68. Short interest is the clearest tension here. Nearly 45.3…
$4.33+5.87% 1d+4.84% 1w-1.37% 1mClose: 6 Nov 2026
- Market cap
- $1.41B
- Next earnings
- 11 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.
Key data as of 7 Nov 2026
TSHA news and analysis
RSSNo long-form analysis yet for TSHA. Pulse alerts and the live data picture are available on ORTEX.
Open TSHA on ORTEX →Want the live picture for TSHA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TSHA — free to start on ORTEX.
Sign up for free →Open TSHA on ORTEX